Hereditary Transthyretin Amyloidosis (HATTR) Report

By www.reliablebusinessinsights.com

Report Details

Report Name

Global And Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size, Status And Forecast 2023-2027 Story

Pages

98

Price

$ 3900

Features

Hereditary Transthyretin Amyloidosis (HATTR) Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Pfizer
Alnylam Pharmaceuticals
Akcea Therapeutics
Prothena
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics Inc